KYNB
Kyntra Bio, Inc.NASDAQ
Healthcare • Biotechnology
Updated 1 day ago
Coverage ready
$5.87-4.08%
Close Oct 13, 2026
- Market cap
- $23.76M
- 1 month
- -26.9%
- 3 months
- -18.6%
- 1 year
- —
- Dividend
- No dividends on record
- Short interest
- 2.8% of float100K shares · settled Sep 30, 2026 · -0.7% since Sep 15, 2026 · FINRA
Fundamentals · trailing 12 months to Jun 30, 2026
- Revenue
- $4.62M
- Net income
- $183.19M
- Free cash flow
- -$38.06M
- Book value
- —
- Total debt
- —
- P/E
- 0.1×
- Price / sales
- 5.1×
- Price / book
- —
- FCF yield
- -160.2%
- Net margin
- +3,967.8%
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if KYNB is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: UNKNOWN
1 top institutions tracked
as of 2026-Q1 (filed 2026-05-15)
Note: 13F filings are reported up to 45 days after quarter-end.Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 6
Largest 13-F holders · Q2 2026
26 filers reported a long position in KYNB for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | $3M | 400K | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $1.2M | 160K | +2.1% |
| ACADIAN ASSET MANAGEMENT LLC | $795K | 105.6K | Unchanged |
| BlackRock, Inc. | $636.7K | 84.3K | 0% |
| GEODE CAPITAL MANAGEMENT, LLC | $326.4K | 43.2K | -6% |
| HighTower Advisors, LLC | $300.1K | 39.7K | 0% |
| TWO SIGMA INVESTMENTS, LP | $298.3K | 39.5K | -20.2% |
| RENAISSANCE TECHNOLOGIES LLC | $204.5K | 27.1K | -1.5% |
| VANGUARD FIDUCIARY TRUST CO | $182K | 24.1K | +0.7% |
| Birchview Capital, LP | $170.4K | 22.6K | Unchanged |
Get the Full Analysis for KYNB
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.